Strategic Advisory Board

The Bionow Strategic Advisory Board is composed of senior individuals from across the North of England representing a cross-section of our membership and the sector as a whole. The Advisory Board advises Bionow offering sector relevant strategic advice and guidance.

The current membership of the Strategic Advisory Board is as follows:

  • Chair: Mike Snowden, VP and Head of Discovery Science, AstraZeneca
  • Graham Bond, Liverpool/Chester Office Managing Partner, RSM
  • Chris Doherty, Independent
  • Paul Found, COO, Fujifilm Diosynth Biotechnologies
  • Catherine Headley, Head of Business Engagement and Knowledge Exchange, University of Manchester
  • Andy Jones, Medicines Manufacturing Industrial Strategy Challenge Fund Director, Innovate UK
  • Kath Mackay, Managing Director, Bruntwood SciTech Alderley Park
  • Neil Murray, CEO, Impact Data Metrics
  • Lloyd Payne, Independent
  • Jonathan Perkins, Director : Global Development Lead, QIAGEN
  • Linda Randall, Associate Vice President, Pharmaron
  • Dave Simpson, CEO, Iksuda Therapeutics
  • Joe de Sousa, Independent
  • Jane Theaker, CEO, Kinomica
  • Simon Wallwork, Partner, Slater Heelis
  • Mark Wigglesworth, Volunteer Director MDC Lighthouse, Medicines Discovery Catapult
  • Ceri Williams, Director of Research and Innovation Development, University of Leeds
  • Peter Simpson, Chief Operating Officer, Medicines Discovery Catapult
  • Steve McConchie, CEO, Aptus Clinical
  • Jonathan O'Halloran, CEO, QuantuMDx
  • Nige Hilton, Head of Manufacturing and Site Leader, Seqirus
  • Claire Eyers, Associate Pro Vice Chancellor (Research & Impact), Faculty of Health and Life Sciences

Our Valued Sponsors & Partners